Cardiovascular disease [dsyn]
Aromatase inhibitor [phsu]
Cardiovascular disease [dsyn]
Old [tmco]
Patients [podg]
Breast Cancer [neop]
Limited [ftcn]
Information [idcn]
Exist [cnce]
Long-Term Effect [phpr]
Aromatase inhibitor [phsu]
cardiovascular cancer [neop]
disease risk [fndg]
Breast [bpoc]
Survivors [podg]
Point [qnco]
Population Based Study [resa]
Able [orga]
cardiovascular risk factor [dsyn]
CARDIOVASCULAR MEDICATIONS [phsu]
Objective [inpr]
influential [idcn]
adjuvant therapy [topp]
Endocrine [bdsy]
Cardiovascular disease [dsyn]
postmenopausal [tmco]
Breast Cancer [neop]
Survivors [podg]
account [idcn]
cardiovascular risk factor [dsyn]
medication use [fndg]
Chemotherapy [topp]
radiotherapy [inpr]
Design [acty]
setting [ftcn]
participants [popg]
retrospective [resa]
postmenopausal [tmco]
Women [popg]
Breast Cancer [neop]
Diagnosed [fndg]
Maximum [qnco]
Person [popg]
Evaluated [ftcn]
Records [inpr]
Managed Care Organization [hcro, mnob]
Hospitals, Community [hcro, mnob]
California [geoa]
postmenopausal [tmco]
Women [popg]
Hormone Receptor [aapp, rcpt]
Breast Cancer [neop]
Prior [tmco]
Cardiovascular disease [dsyn]
included [ftcn]
Cardiovascular disease [dsyn]
Compared [acty]
Endocrine therapy [topp]
Categories [inpr]
Information [idcn]
Demographics [idcn]
Comorbidity [idcn]
Medication [phsu]
Cardiovascular disease [dsyn]
Electronic Health Records [inpr]
Cox Proportional Hazards Models [inpr, qnco]
dependent drug [fndg]
Endocrine [bdsy]
variables [qlco]
Scores, Propensity [qnco]
Conduct [inbe]
Data Analysis [ocac]
Conduct [inbe]
exposures [inpo]
Women [popg]
Grouped [spco]
Endocrine therapy [topp]
Status [qlco]
Tamoxifen Citrate [orch, phsu]
Aromatase inhibitor [phsu]
Main [qlco]
Measure [qnco]
Person [popg]
Cardiovascular disease [dsyn]
therapy [ftcn]
Group [idcn]
Person [popg]
Women [popg]
SD [fndg]
Age [orga]
Observed [ftcn]
cardiovascular events [fndg]
Reported [inpr]
Hazard Ratio [qnco]
Aromatase inhibitor [phsu]
Users [humn]
cardiac ischaemia [dsyn]
Myocardial Infarction [dsyn]
Angina [sosy]
Adjusted [ftcn]
Stroke [dsyn]
Adjusted [ftcn]
Tamoxifen [orch, phsu]
Users [humn]
Reference [idcn]
Increased [qnco]
Cardiovascular disease [dsyn]
dysrhythmia [patf]
dysfunction [ftcn]
Pericarditis [dsyn]
Adjusted [ftcn]
Women [popg]
Tamoxifen [orch, phsu]
Tamoxifen [orch, phsu]
Reference [idcn]
Well [qlco]
Users [humn]
Conclusions [idcn]
Relevance [qlco]
Serious [qlco]
cardiovascular events [fndg]
cardiac ischaemia [dsyn]
Stroke [dsyn]
Elevated [qlco]
Aromatase inhibitor [phsu]
Users [humn]
Compared [acty]
Tamoxifen [orch, phsu]
Users [humn]
Finding [sosy]
cardiovascular events [fndg]
Combined [qlco]
Aromatase inhibitor [phsu]
Users [humn]
Study [mnob]
